Cor Vasa 2011, 53(8-9):466-469 | DOI: 10.33678/cor.2011.116

Vascular access for hemodialysis: from renal hypertension to hemodynamics

Jaroslav Kudlička*, Jan Malík
Centrum pro výzkum, diagnostiku a léčbu arteriální hypertenze, III. interní klinika, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

The creation of the dialysis vascular access has local and systemic hemodynamic effects. Decrease in the local vascular resistance leads to the acceleration of blood flow, which increases vascular wall shear stress. This ultimately leads to increased production of nitric oxide, dilatation of the feeding artery and increase of blood flow to the limb. High blood flow can cause decompensation of chronic congestive heart failure, less often hyperkinetic heart failure. The most common local complication is ischemia of the limb with the access. The lifespan of native fistulas and accesses with PTFE grafts is limited by the development of stenosis, which leads to the reduction in flow and increases the risk of acute thrombosis and access failure. Regular ultrasonographic screening allows an adequate monitoring of the access flow and quantification of stenoses, which helps to time the vascular intervention. The complexity of care is provided by a multidisciplinary team in specialized centre; we make efforts to develop this cooperation on a national level.

Keywords: Vascular access for hemodialysis; Local and systemic hemodynamics; Ultrasonography

Published: August 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kudlička J, Malík J. Vascular access for hemodialysis: from renal hypertension to hemodynamics. Cor Vasa. 2011;53(8-9):466-469. doi: 10.33678/cor.2011.116.
Download citation

References

  1. Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in U.S. Hemodialysis patients. Kidney Int 2001;60:1443-1451. Go to original source... Go to PubMed...
  2. Wasse H, Speckman RA, McClellan WM. Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial 2008;21:483-489. Go to original source... Go to PubMed...
  3. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48 (Suppl 1): S176-273.
  4. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 2010;74:24-33. Go to original source... Go to PubMed...
  5. Bauer V, Sotníková R. Nitric oxide-the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys 2010;29:319-40. Go to original source...
  6. Rotreklová J, Molinský J, Tuka V, Malík J. Smykové napětí a endotel. Čas Lék Čes 2004;143:467-470.
  7. Chytilová E, Malík J. Smykové napětí v karotidách a jeho role v rozvoji aterosklerózy. Vnitř Lék 2007;53:377-381. Go to PubMed...
  8. Tuka V, Slavíková M, Kasalová Z, Malík J. Factors associated with impaired arterial adaptation to chronically high wall shear rate in the feeding artery of PTFE grafts. Am J Nephrol 2008;28:847-852. Go to original source... Go to PubMed...
  9. Allon M, Lok CE. Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol 2010;5:2348-2354. Go to original source... Go to PubMed...
  10. Roy-Chaudhury P, Kelly BS, Zhang J, et al. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif 2003;21:99-110. Go to original source... Go to PubMed...
  11. Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis 2009;16:329-338. Go to original source... Go to PubMed...
  12. Abassi Z, Nakhoul F, Khankin E, et al. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens 2006;15:353-360. Go to original source... Go to PubMed...
  13. Malík J, Tuka V, Krupičková Z, et al. Creation of dialysis vascular access with normal flow increases brain natriuretic peptide levels. Int Urol Nephrol 2009;41:997-1002. Go to original source... Go to PubMed...
  14. Bos WJW, Zietse R, Wesseling KH, Westerhof N. Effect of arteriovenous fistulas on cardiac oxygen supply and demand. Kidney Int 1999;55:2049-2053. Go to original source... Go to PubMed...
  15. Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous fistula. Hemodial Int 2011;15:104-107. Go to original source... Go to PubMed...
  16. Malík J, Tuka V, Mokrejšová M, et al. Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res 2009;58:613-621. Go to original source...
  17. Malík J, Tuka V, Kasalová Z, et al. Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access 2008;9:155-166. Go to original source... Go to PubMed...
  18. Schild AF. Maintaining vascular access: the management of hemodialysis arteriovenous grafts. J Vasc Access 2010;11:92-99. Go to original source... Go to PubMed...
  19. Ferring M, Claridge M, Smith SA, Wilmink T. Routine preoperative vascular ultrasound improves patency and use of arteriovenous fistulas for hemodialysis: a randomized trial. Clin J Am Soc Nephrol 2010;5:2236-2244. Go to original source... Go to PubMed...
  20. Hindle P, Ritchie J, Griffith G, Howd A. Use of early scanning in fistula formation for vascular access. J Vasc Access 2011;12:127-129. Go to original source... Go to PubMed...
  21. Malík J, Slaviková M, Svobodová J, Tuka V. Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney Int 2005;67:1554-1558. Go to original source... Go to PubMed...
  22. van der Linden J, Smits JH, Assink JH, et al. Short- and long-term functional effects of percutaneous transluminal angioplasty in hemodialysis vascular access. J Am Soc Nephrol 2002;13:715-720. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.